Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: Results from cancer and leukemia group B 9712 (CALGB 9712)

  • John C. Byrd
  • , Bercedis L. Peterson
  • , Vicki A Morrison
  • , Kathleen Park
  • , Robert Jacobson
  • , Eva Hoke
  • , James W. Vardiman
  • , Kanti Rai
  • , Charles A. Schiffer
  • , Richard A. Larson

Research output: Contribution to journal › Article › peer-review

530 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: Results from cancer and leukemia group B 9712 (CALGB 9712)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience